Li et al. demonstrated that thymosinalpha1 stimulated pancreatic cancer cell proliferation with the increase in IL-13 accompanying the activation of ERK1/2 and c-Jun N-terminal kinase (JNK) [94]. Here, MAPK3 is linked to pancreatic neoplasm.